Paul Mehta

1.7k total citations · 1 hit paper
47 papers, 1.1k citations indexed

About

Paul Mehta is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Paul Mehta has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 21 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Paul Mehta's work include Amyotrophic Lateral Sclerosis Research (44 papers), Neurogenetic and Muscular Disorders Research (21 papers) and Prion Diseases and Protein Misfolding (10 papers). Paul Mehta is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (44 papers), Neurogenetic and Muscular Disorders Research (21 papers) and Prion Diseases and Protein Misfolding (10 papers). Paul Mehta collaborates with scholars based in United States, Australia and Netherlands. Paul Mehta's co-authors include D. Kevin Horton, Wendy Kaye, Theodore Larson, Jaime Raymond, Oleg Muravov, Reshma Punjani, Ruoming Wu, Jessica Cohen, Tracy L. Peters and Daniel Heller and has published in prestigious journals such as JAMA, PLoS ONE and Neurology.

In The Last Decade

Paul Mehta

44 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Amyotrophic Lateral Sclerosis — United States, 2014

2018 276 citations Paul Mehta, Wendy Kaye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Mehta United States	18	817	437	270	104	74	47	1.1k
Aleksandar Radunović United Kingdom	17	615 0.8×	385 0.9×	282 1.0×	117 1.1×	92 1.2×	45	998
Bryan Traynor United States	11	950 1.2×	575 1.3×	249 0.9×	177 1.7×	91 1.2×	20	1.1k
Oleg Muravov United States	10	463 0.6×	243 0.6×	152 0.6×	66 0.6×	53 0.7×	12	721
Shuna Colville United Kingdom	16	759 0.9×	380 0.9×	142 0.5×	132 1.3×	76 1.0×	27	973
Reshma Punjani United States	9	459 0.6×	237 0.5×	146 0.5×	65 0.6×	49 0.7×	13	610
Jinsy Andrews United States	19	748 0.9×	558 1.3×	196 0.7×	85 0.8×	84 1.1×	40	945
Magdalena Kuźma‐Kozakiewicz Poland	17	661 0.8×	396 0.9×	300 1.1×	129 1.2×	122 1.6×	72	959
Caroline Ingre Sweden	22	1.1k 1.4×	567 1.3×	379 1.4×	242 2.3×	157 2.1×	59	1.4k
Stefania Cammarosano Italy	14	810 1.0×	359 0.8×	114 0.4×	112 1.1×	66 0.9×	24	920
J D Mitchell United Kingdom	16	997 1.2×	474 1.1×	344 1.3×	195 1.9×	140 1.9×	22	1.3k

Countries citing papers authored by Paul Mehta

Since Specialization

Citations

This map shows the geographic impact of Paul Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Mehta more than expected).

Fields of papers citing papers by Paul Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Mehta. The network helps show where Paul Mehta may publish in the future.

Co-authorship network of co-authors of Paul Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Mehta. A scholar is included among the top collaborators of Paul Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Mehta. Paul Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mehta, Paul, Jaime Raymond, Reshma Punjani, et al.. (2025). Incidence of ALS in all 50 states in the United States, data from the National ALS Registry, 2012–2019. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 26(7-8). 758–766. 1 indexed citations

Mehta, Paul, Jaime Raymond, J.L. Berry, et al.. (2025). Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 26(3-4). 290–295. 5 indexed citations

Banack, Sandra Anne, et al.. (2024). A microRNA diagnostic biomarker for amyotrophic lateral sclerosis. Brain Communications. 6(5). fcae268–fcae268. 17 indexed citations

Raymond, Jaime, et al.. (2024). Racial Disparities in the Diagnosis and Prognosis of ALS Patients in the United States. Journal of Racial and Ethnic Health Disparities. 12(5). 2915–2921. 3 indexed citations

Boyce, Danielle, et al.. (2024). What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 25(5-6). 615–624. 1 indexed citations

Raymond, Jaime, James D. Berry, Theodore Larson, D. Kevin Horton, & Paul Mehta. (2024). Effects of COVID-19 on motor neuron disease mortality in the United States: a population-based cross-sectional study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 26(1-2). 149–156. 2 indexed citations

Raymond, Jaime, J.L. Berry, Edward J. Kasarskis, et al.. (2023). A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010–2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 25(1-2). 211–213. 2 indexed citations

Larson, Theodore, et al.. (2023). Causes of death among United States decedents with ALS: An eye toward delaying mortality. Annals of Clinical and Translational Neurology. 10(5). 757–764. 8 indexed citations

Banack, Sandra Anne, Rachael A. Dunlop, Elijah W. Stommel, Paul Mehta, & Paul Alan Cox. (2022). miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 442. 120396–120396. 36 indexed citations

10.

Bledsoe, Marianna J., Lindsay Rechtman, Laurie Wagner, et al.. (2021). Analysis of Biospecimen Demand and Utilization of Samples from the National Amyotrophic Lateral Sclerosis Biorepository. Biopreservation and Biobanking. 19(5). 432–437. 1 indexed citations

11.

Raymond, Jaime, et al.. (2021). Reproductive History and Age of Onset for Women Diagnosed with Amyotrophic Lateral Sclerosis: Data from the National ALS Registry: 2010–2018. Neuroepidemiology. 55(5). 416–424. 12 indexed citations

12.

Andrew, Angeline S., Erik P. Pioro, Meifang Li, et al.. (2021). The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry. Neuroepidemiology. 55(3). 196–205. 6 indexed citations

13.

Mehta, Paul, Jaime Raymond, Theodore Larson, et al.. (2021). Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism. Journal of Medical Internet Research. 23(12). e28021–e28021. 7 indexed citations

14.

Nelson, Lorene M., Barbara Topol, Wendy Kaye, et al.. (2021). Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method. Neuroepidemiology. 56(2). 104–114. 5 indexed citations

15.

Mehta, Paul, et al.. (2020). Challenges and Limitations of Ascertaining Amyotrophic Lateral Sclerosis (ALS) Cases in the United States (842). Neurology. 94(15_supplement). 1 indexed citations

16.

Bhattacharya, Rituparna, et al.. (2019). Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20(3-4). 251–259. 9 indexed citations

17.

Nelson, Lorene M., Barbara Topol, Wendy Kaye, et al.. (2018). Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology. Neuroepidemiology. 51(3-4). 149–157. 20 indexed citations

18.

Larson, Theodore, Wendy Kaye, Paul Mehta, & D. Kevin Horton. (2018). Amyotrophic Lateral Sclerosis Mortality in the United States, 2011–2014. Neuroepidemiology. 51(1-2). 96–103. 27 indexed citations

19.

Bryan, Leah, Wendy Kaye, Vinicius C. Antao, et al.. (2016). Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data. PLoS ONE. 11(4). e0153683–e0153683. 21 indexed citations

20.

Mehta, Paul, et al.. (2012). 327 Ischemic Heart Disease in Metis in Manitoba: Results From the Ischemic Heart Disease and Related Health Care Utilization Study. Canadian Journal of Cardiology. 28(5). S219–S219. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact